Erythropoiesis defect observed in STAT3 GOF patients with severe anemia
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (4) , 1297-1301
Abstract
No abstract availableFunding Information
- Universität Zürich
This publication has 9 references indexed in Scilit:
- Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic ReviewThe Journal of Allergy and Clinical Immunology: In Practice, 2019
- Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutationsJournal of Allergy and Clinical Immunology, 2018
- Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?Hormone Research in Paediatrics, 2017
- Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO MutationCell, 2017
- Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutationsBlood, 2015
- Stat5 Signaling Specifies Basal versus Stress Erythropoietic Responses through Distinct Binary and Graded Dynamic ModalitiesPLOS Biology, 2012
- Global gene expression analysis of human erythroid progenitorsBlood, 2011
- The majority of the in vitro erythroid expansion potential resides in CD34- cells, outweighing the contribution of CD34+ cells and significantly increasing the erythroblast yield from peripheral blood samplesHaematologica, 2010
- Ineffective erythropoiesis in Stat5a−/−5b−/− mice due to decreased survival of early erythroblastsBlood, 2001